Literature DB >> 21982880

Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.

Zhilong Ren1, Wei Liang1, Cheng Chen1, Hongxia Yang1, Pravin C Singhal2, Guohua Ding3.   

Abstract

Nephrin, an important structural and signal molecule of podocyte slit-diaphragm (SD), has been suggested to contribute to the angiotensin II (Ang II)-induced podocyte injury. Caveolin-1 has been demonstrated to play a crucial role in signaling transduction. In the present study, we evaluated the role of caveolin-1 in Ang II-induced nephrin phosphorylation in podocytes. Wistar rats-receiving either Ang II (400 ng/kg/min) or normal saline (via subcutaneous osmotic mini-pumps, control) were administered either vehicle or telmisartan (3 mg/kg/min) for 14 or 28 days. Blood pressure, 24-hour urinary albumin and serum biochemical profile were measured at the end of the experimental period. Renal histomorphology was evaluated through light and electron microscopy. In vitro, cultured murine podocytes were exposed to Ang II (10(-6)M) pretreated with or without losartan (10(-5) M) for variable time periods. Nephrin and caveolin-1 expression and their phosphorylation were analyzed by Western-blotting and immunofluorescence. Caveolar membrane fractions were isolated by sucrose density gradient centrifugation, and then the distribution and interactions between Ang II type 1 receptor (AT1), nephrin, C-terminal Src kinase (Csk) and caveolin-1 were evaluated using Western-blotting and co-immunoprecipitation. Podocyte apoptosis was evaluated by cell nucleus staining with Hoechst-33342. Ang II-receiving rats displayed diminished phosphorylation of nephrin but enhanced glomerular/podocyte injury and proteinuria when compared to control rats. Under control conditions, podocyte displayed expression of caveolin-1 in abundance but only a low level of phospho moiety. Nonetheless, Ang II stimulated caveolin-1 phosphorylation without any change in total protein expression. Nephrin and caveolin-1 were co-localized in caveolae fractions. AT1 receptors and Csk were moved to caveolae fractions and had an interaction with caveolin-1 after the stimulation with Ang II. Transfection of caveolin-1 plasmid (pEGFPC3-cav-1) significantly increased Ang II-induced nephrin dephosphorylation and podocyte apoptosis. Furthermore, knockdown of caveolin-1 expression (using siRNA) inhibited nephrin dephosphorylation and prevented Ang II-induced podocyte apoptosis. These findings indicate that Ang II induces nephrin dephosphorylation and podocyte injury through a caveolin-1-dependent mechanism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982880      PMCID: PMC3237911          DOI: 10.1016/j.cellsig.2011.09.022

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  28 in total

1.  SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin.

Authors:  Hongping Li; Serge Lemay; Lamine Aoudjit; Hiroshi Kawachi; Tomoko Takano
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

2.  Rat nephrin modulates cell morphology via the adaptor protein Nck.

Authors:  Hongping Li; Jianxin Zhu; Lamine Aoudjit; Mathieu Latreille; Hiroshi Kawachi; Louise Larose; Tomoko Takano
Journal:  Biochem Biophys Res Commun       Date:  2006-08-17       Impact factor: 3.575

Review 3.  Renin-angiotensin-aldosterone system and progression of renal disease.

Authors:  Christiane Rüster; Gunter Wolf
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

4.  Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases.

Authors:  Juhani Lahdenperä; Pekka Kilpeläinen; Xiao Li Liu; Timo Pikkarainen; Paula Reponen; Vesa Ruotsalainen; Karl Tryggvason
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

5.  Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

Authors:  Junya Jia; Guohua Ding; Jili Zhu; Cheng Chen; Wei Liang; Nicholas Franki; Pravin C Singhal
Journal:  Am J Nephrol       Date:  2008-01-17       Impact factor: 3.754

6.  Activation of a local renin angiotensin system in podocytes by glucose.

Authors:  Raghu V Durvasula; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

7.  Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization.

Authors:  Rakesh Verma; Iulia Kovari; Abdul Soofi; Deepak Nihalani; Kevin Patrie; Lawrence B Holzman
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

8.  Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1.

Authors:  Mark C Wagner; George Rhodes; Exing Wang; Vikas Pruthi; Ehtesham Arif; Moin A Saleem; Sarah E Wean; Puneet Garg; Rakesh Verma; Lawrence B Holzman; Vince Gattone; Bruce A Molitoris; Deepak Nihalani
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

9.  Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes.

Authors:  Nina Jones; Ivan M Blasutig; Vera Eremina; Julie M Ruston; Friedhelm Bladt; Hongping Li; Haiming Huang; Louise Larose; Shawn S-C Li; Tomoko Takano; Susan E Quaggin; Tony Pawson
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

10.  Glomerular endothelial fenestrae in vivo are not formed from caveolae.

Authors:  Jenny Sörensson; Wolfgang Fierlbeck; Torsten Heider; Karin Schwarz; David S Park; Peter Mundel; Michael Lisanti; Barbara J Ballermann
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

View more
  33 in total

Review 1.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

Review 2.  Oxidative Stress and Hypertensive Diseases.

Authors:  Roxana Loperena; David G Harrison
Journal:  Med Clin North Am       Date:  2016-10-27       Impact factor: 5.456

Review 3.  Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Authors:  Richard Van Krieken; Joan C Krepinsky
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

Review 4.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 6.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

7.  Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN).

Authors:  Kang Cheng; Partab Rai; Andrei Plagov; Xiqian Lan; Peter W Mathieson; Moin A Saleem; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2013-04-21       Impact factor: 3.905

8.  Human podocytes perform polarized, caveolae-dependent albumin endocytosis.

Authors:  Evgenia Dobrinskikh; Kayo Okamura; Jeffrey B Kopp; R Brian Doctor; Judith Blaine
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 9.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

10.  Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1.

Authors:  Xiaoyang Wan; Zhaohong Chen; Won-Il Choi; Heon Yung Gee; Friedhelm Hildebrandt; Weibin Zhou
Journal:  J Am Soc Nephrol       Date:  2015-08-11       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.